Abu Dhabi Investment Office (ADIO) has announced a strategic agreement with German biotechnology company Bayer aimed at establishing a framework to explore collaboration across health, life sciences, food security, philanthropy and innovation ecosystems.
The fourth Riyadh Global Medical Biotechnology Summit (RGMBS) will bring together leading experts, researchers, innovators, investors and policymakers from around the world to discuss the latest developments in medical biotechnology.
